𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regulatory perspectives on clinical trials for trauma, transfusion, and hemostasis

✍ Scribed by Toby Silverman; Paul Aebersold; Laurence Landow; Kimberly Lindsey

Book ID
110744179
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
83 KB
Volume
45
Category
Article
ISSN
0372-1248

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rituximab therapy for thrombotic thrombo
Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders
✍ James N. George; Robert D. Woodson; Joseph E. Kiss; Kiarash Kojouri; Sara K. Ves πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 101 KB

## Abstract The rationale for immunosuppressive therapy of thrombotic thrombocytopenic purpura (TTP) was established by observations that TTP may be caused by autoantibodies to ADAMTS13. Patients with high‐titer autoantibodies to ADAMTS13 may have a higher mortality, and survivors may require prolo